SEC Form 4/A · accession 0001225208-15-008455
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Nicholas J Valeriani
Director
Period of report
Nov 13, 2014
Accepted (ET)
Mar 24, 2015 · 5:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Acquire)F1,F2 | $124.55 | Nov 13, 2014 | A | 5,768 | A | Nov 13, 2015 | Nov 12, 2021 | Common Stock | 5,768 | 5,768 | D |
Explanation of responses
- F1This option was granted on November 13, 2014 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and becomes exercisable commencing one year after the grant date in three equal annual installments.
- F2This amendment corrects the number of options which was initially incorrect due to an administrative error.